ArticleFrontiers in medicine2024

Case report: Vedolizumab in Oral Crohn's disease: the downsides of a gut-specific therapy for a multi-site disease.

Molly Harte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.